Not Everyone Should Get COVID Vaccine, States the Association of American Physicians and Surgeons (AAPS)
August 13, 2021 12:48 ET
|
Association of American Physicians and Surgeons
TUCSON, Ariz., Aug. 13, 2021 (GLOBE NEWSWIRE) -- The voluntary COVID-19 vaccination program has failed to achieve 100 percent compliance, and coercive measures are increasing, even before any...
Sunshine Biopharma’s Coronavirus Treatment Anticipated to be Effective Against Delta and the Other Variants of Concern
August 12, 2021 09:00 ET
|
Sunshine Biopharma Inc.
MONTREAL, Aug. 12, 2021 (GLOBE NEWSWIRE) -- Sunshine Biopharma Inc. (OTC Pink: “SBFM”), a pharmaceutical company focused on the research, development and commercialization of oncology and antiviral...
Dyadic and Sorrento Announce Binding Term Sheet to License Dyadic’s Lead COVID-19 Vaccine Candidate “DYAI-100” and C1 Technology for Protein-Based Coronavirus Vaccines and Therapeutics
August 11, 2021 08:35 ET
|
Dyadic International, Inc.
Sorrento to obtain exclusive rights in North and South America, Europe, major Asian countries (including Greater China and Japan) and certain other countries to utilize Dyadic’s C1 technology for the...
ALABAMA SENATOR DIAL JOINS FOMO’S ADVISORY BOARD; OP-ED PUBLISHED ON BEATING COVID’S DELTA VARIANT
July 27, 2021 13:53 ET
|
FOMO CORP.
Chicago IL, July 27, 2021 (GLOBE NEWSWIRE) -- FOMO CORP. (OTC: FOMC) is pleased to announce that Retired Senator Gerald Dial (R: Alabama 13th District) has joined FOMO’s Advisory Board. Senator Dial...
Axiom Medical, an innovator in occupational health services for employers, announced it has exceeded ten million check ins on the leading edge CheckIn2Work mobile app
July 20, 2021 11:47 ET
|
Axiom Medical
Houston, TX, July 20, 2021 (GLOBE NEWSWIRE) -- CheckIn2Work reduces the risk of workplace COVID-19 and infectious disease outbreak with 24-7 mobile device-based self-service Daily Health...
Dyadic’s C1 Production Platform Utilized in ZAPI Study Published in “VACCINES” a Leading Peer-Reviewed Scientific Journal
June 28, 2021 08:30 ET
|
Dyadic International, Inc.
Dyadic’s C1-cell protein production platform selected as a fast response vaccine manufacturing model against zoonotic diseases.C1 -cell platform expressed SBV antigen exhibited efficacy, potency, and...